tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Mersana Therapeutics reports Q3 EPS ($1.51), consensus (89c)
PremiumThe FlyMersana Therapeutics reports Q3 EPS ($1.51), consensus (89c)
2M ago
Mersana Therapeutics downgraded to Market Perform from Outperform at William Blair
Premium
The Fly
Mersana Therapeutics downgraded to Market Perform from Outperform at William Blair
2M ago
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
2M ago
Mersana Therapeutics Announces Merger with Day One
PremiumCompany AnnouncementsMersana Therapeutics Announces Merger with Day One
2M ago
Day One Biopharmaceuticals to acquire Mersana Therapeutics for up to $285M
Premium
The Fly
Day One Biopharmaceuticals to acquire Mersana Therapeutics for up to $285M
2M ago
Day One Biopharmaceuticals to acquire Mersana Therapeutics for up to $285M
Premium
The Fly
Day One Biopharmaceuticals to acquire Mersana Therapeutics for up to $285M
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100